Tirzepatide – commonly known as Mounjaro™ – is FDA-approved for controlling diabetes.  In obesity cases the active ingredient Tirzepatide is being prescribed by doctors for weight loss. Tirzepatide produces weight loss by stimulating two satiety hormone receptors instead of just one with Semaglutide.
 
Dosage and Frequency
Once a week
Taken on the same day each week, any time of day, with or without food.
SEE INGREDIENTS BELOW
(Detailed dosing schedule will be provided with Homekit)